Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Biogen Norway AS
AS
Active
Org 980785122
Vitaminveien 1A, 0485
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1999 · 27 years old
7 employees
www.biogenidec.no
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Biogen Norway AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
589M
442M
295M
147M
0M
2020: 473M
473M
2020
2021: 385M (-19% vs 2020)
385M
-19%
2021
2022: 284M (-26% vs 2021)
284M
-26%
2022
2023: 254M (-11% vs 2022)
254M
-11%
2023
2024: 288M (+13% vs 2023)
288M
+13%
2024
EBITDA
NOK millions
30M
22M
15M
7M
0M
2020: 24M
24M
2020
2021: 18M (-25% vs 2020)
18M
-25%
2021
2022: 10M (-44% vs 2021)
10M
-44%
2022
2023: 10M (0% vs 2022)
10M
0%
2023
2024: 10M (0% vs 2023)
10M
0%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
287 946
253 925
284 385
385 429
473 440
Staff expenses
−0
−0
−0
−33 317
−26 840
EBITDA
10 096
9 871
9 883
18 092
23 633
Depreciation & amort.
−21
−134
−88
−119
−317
EBIT
10 075
9 737
9 795
17 973
23 316
Net financials
5 401
2 455
−231
−390
10
Profit before tax
15 476
12 192
9 564
17 583
23 326
Tax
−0
−0
−0
3 878
5 135
Net profit
12 065
9 493
7 450
13 705
18 190
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
233 915
210 748
198 402
216 560
205 038
Equity
185 219
173 155
163 662
156 212
142 507
Long-term debt
0
0
0
0
0
Short-term debt
48 696
37 593
34 740
60 348
62 530
Total debt
48 696
37 593
34 740
60 348
62 530
Financial ratios
5-year trend
EBITDA margin
3,5 %
This company
15,8 %
Market median
This company
Market median
78% below market
2020
2024
Equity ratio
79,2 %
This company
38,2 %
Market median
This company
Market median
107% above market
2020
2024
Return on equity
6,5 %
This company
18,4 %
Market median
This company
Market median
65% below market
2020
2024
Net profit margin
4,2 %
This company
8,1 %
Market median
This company
Market median
48% below market
2020
2024
Asset turnover
1,23×
This company
1,12×
Market median
This company
Market median
10% above market
2020
2024
Debt / equity
0,26×
This company
0,62×
Market median
This company
Market median
58% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Biogen Norway AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
